Tag Archive for: COVID-19

COVID-19 Vaccine Safety in Pregnancy

Authors: Sue Lu, BSc student in Integrated Science at the University of British Columbia and Research Assistant at the Vaccine Evaluation Centre; Manish Sadarangani, MRCPCH, DPHIL, BM.BCh, MA, Director of the Vaccine Evaluation Center at BC Children’s Hospital and Associate Professor in the Department of Pediatrics at the University of British Columbia Authors/Editors: Romina Garcia de leon, Shayda Swann (Blog Co-coordinators).

Published: April 21st, 2023

The COVID-19 pandemic has disproportionately impacted pregnant people. If a pregnant person is infected with SARS-CoV-2, the virus that causes COVID-19, they are at a higher risk of severe disease, hospitalization, intensive care unit admission, and death. COVID-19 infection in pregnant people can also cause poor pregnancy outcomes, such as preterm birth and impaired fetal growth. As found by UBC researchers through the CANCOVID-Preg surveillance program, even cases of mild COVID-19 infection not requiring hospitalization were significantly associated with a higher risk of preterm birth.  In short, COVID-19 is not only threatening to the mother, but to the unborn child as well. 

What did we know about the safety of COVID-19 vaccines in pregnancy?

COVID-19 vaccines have been available in Canada since December 2020. Experts recommended COVID-19 vaccines during pregnancy based on smaller studies of other mRNA vaccines in pregnancy and several decades of administering vaccines in pregnancy. Unfortunately, despite the continued recommendations from experts to get vaccinated, many pregnant people remained hesitant about the COVID-19 vaccines. In fact, recent studies suggest that 49% of pregnant women were accepting of COVID-19 vaccines. 

How did we conduct this study?

This study was conducted through the Canadian National Vaccine Safety (CANVAS) Network. The CANVAS Network is a national research platform that monitors the safety of vaccines, including COVID-19 vaccines, in Canada. This study, led by Dr. Manish Sadarangani, looked at the frequency and nature of severe health events following vaccination in pregnant people. Severe health events, as defined by this study and other CANVAS Network studies, are issues that arise following vaccination that are severe enough to prevent people from going to work or school, or required medical attention.

At the time this study was conducted, over 700,000 total participants and 5,500 pregnant individuals had enrolled from seven provinces and territories across Canada. We looked at female participants of reproductive age and compared how pregnant people reacted to their first and second doses of the COVID-19 vaccines in unvaccinated pregnant people and vaccinated non-pregnant people. 

Overall, this CANVAS Network study allowed us to better understand COVID-19 vaccine safety by looking at changes to health after vaccination for pregnant people and comparing their changes to those of similar vaccinated and unvaccinated groups. 

What did we learn? 

Our study’s findings confirmed that COVID-19 mRNA vaccines are safe to use in pregnancy. Additionally, other studies show them to be both effective and immunogenic, meaning they can protect both the mother and the child from COVID-19 infection. Here are three of our major safety findings: 

  1. COVID-19 mRNA vaccine reaction differences between pregnant and non-pregnant individuals: When we compared pregnant and non-pregnant vaccinated individuals, we found that pregnant people experienced fewer symptoms that prevented daily activities, prevented work, or required a medical visit than non-pregnant people. 
  2. COVID-19 mRNA vaccine reaction differences between vaccinated and unvaccinated pregnant individuals: There was no difference in hospitalization or pregnancy-related complications in these two groups, suggesting that vaccination did not have negative impacts on pregnancy. 
  3. Moderna vaccine: After a second dose of the Moderna mRNA vaccine, vaccinated pregnant people reported more symptoms than unvaccinated pregnant people, but reported similar symptoms to vaccinated non-pregnant people. Vaccinated pregnant people and unvaccinated pregnant people were also more likely to seek care for these symptoms than vaccinated non-pregnant people.

Overall, mRNA vaccines are safe and effective in pregnancy. As this study shows, getting vaccinated against COVID-19 does not increase the risk of miscarriages or other pregnancy complications. 

How can you use this information?

If you’re a health care worker, we hope that this study will provide some insight into the common symptoms that pregnant people may experience after vaccination. Common symptoms following vaccination include redness and pain at the injection site, fatigue, muscle aches, and headaches. This information, from Canada’s top vaccine researchers, can also be used to counter misinformation about vaccines that pregnant people may have encountered.

You can read a full summary of the study here, or check out the full context in the published journal article here

The bottom line? Get vaccinated against COVID-19 and protect yourself (and your child)!

 

Behind the Science: Promoting Women’s Mental HealthThrough Social Interventions

Authors: Romina Garicia de leon and Negin Nia, Women’s Health Blog Coordinators | Interviewee: Dr. Saima Hirani, Ph.D., University of British Columbia

Published: September 9th, 2022 

Can you please tell us a bit about your career trajectory as a registered nurse, and now Assistant Professor of Nursing?

I’m an internationally educated nurse. I completed my Bachelors of Science and Master of Science in Nursing from The Aga Khan University in Pakistan. I began  my nursing career as an intensive care unit and cardiac intensive care unit nurse in Pakistan, which involved a lot of technical, high tech, critical care.

I then came to Canada and completed my PhD in Nursing with a focus on mental health at the University of Alberta. After PhD, I went back to Pakistan and worked as an Assistant Professor in the Aga Khan University. In 2019, I joined University of British Columbia (UBC) as a postdoctoral research fellow and currently, I am Assistant Professor,  at UBC,  School of Nursing.

What got you interested in Mental health Nursing? 

After I started working in the ICU, I got some experience with mental health nursing and I got to work with a variety of women, some of whom were incarcerated, survivors of sexual assault or domestic violence. This got me interested in mental health, and many of my teachers recommended me to enter the field.  In 2007, I joined a multidisciplinary research project as a co-investigator that aimed to promote mental health and empowerment in women. My master’s thesis was also part of that larger project. By the time I came to Canada for my PhD, it was very clear that I wanted to focus on women’s health and mental health specifically. My PhD focused on development and testing of social support intervention for women’s resilience and quality of life. My program of research mainly focuses on mental health promotion of individuals including women who live in socioeconomic disadvantaged settings. 

You recently published a paper on COVID-19 and its effects on mental health. Can you elaborate on that study? 

So that was a team that I was working with during my postdoctoral work. Dr. Emily Jenkins led this work which was about the impact of COVID-19 on Canadian Mental Health. The first findings that we published showed  an anticipated change in mental health issues among the population, and especially women experienced more mental health issues than men, globally. COVID-19 has affected women badly, as we all know there are some social issues at play. For example, many working women were also taking care of kids at home so there is a double burden. Sex differences were also observed for employment losses i.e. women’s employment has been affected more than men.There’s actually a layer of complexity into women’s well being and in turn the well being of the families and the children. 

You touched a bit on this, but why is women’s health important to you?

Women’s Health has been very close to me for a long time. This passion started when I was a master’s student 15 years ago. I actually joined a multidisciplinary research team back in Pakistan, and it was made up of nurses, psychologists, and psychiatrists. The team’s goal was to develop and test economic skill building and life skill interventions for women, and that’s where my masters thesis came from. So I actually developed and tested that lifestyle building intervention and tested it for feasibility. Intervention development is not an easy task, I went through a lot  of literature, and interviewed several women who were living in some more vulnerable conditions, and some low socio economic communities. I would go to the urban slum areas of Karachi, Pakistan to work with these women. I learnt a lot from these women, it was a life changing experience for me. That was what laid the foundation for my work. After 15 years, I’m still very passionate about that work. 

And the way I think about it is, there are the two main reasons women’s health is important. The first and foremost is, women’s health is directly linked with the children and families health, which is the cornerstone of a family’s overall health. Working in different contexts  of Pakistan and Canada, I learnt that  in general women and mothers play the same roles across countries. There are some universal gender roles attached to women, therefore, women’s mental health is directly associated with their children’s wellbeing.  To pay attention to women’s health and well being is to make children’s lives better and create healthier families. 

And the second reason to focus on women’s health is the high prevalence and high risk of developing certain health challenges among women, as women experience unique healthcare issues more than men. Such as reproductive health issues, violence and abuse, depression and anxiety. These issues are more prevalent globally, and not only in low and middle income women. Moreover, women don’t just experience higher prevalence to diseases but more barriers in accessing  health care than men. Some women may lack economic independence in certain countries, meaning no or lack of education opportunities, or unemployment. If women don’t have the freedom to decide for themselves, this creates a large barrier to reach out for help and support.  Mostly, I’ve seen these issues come up in Pakistan, when women get married. A lot  of attention goes to their families and children, leading them to overlook their own health. So I think this realization and awareness drove the focus of my research, and to empower women, and help them prioritize their health. 

Where can people go to learn more about the work that you do? 

I have  twitter @HiraniSaima and people can look at my Google Scholar or PubMed

 

How to Set Yourself and Baby up for Breastfeeding Success During COVID-19

 

Author: Carrie Miller, Ph.D., RN, CNE, CHSE, IBCLC, Seattle University-College of Nursing | Editors: Negin Nia, Arrthy Thayaparan (Blog Coordinators), and Kiranjot Jhajj (Blog Reviewer) 

Published: May 6th, 2022

We exist because someone fed us when we were born. In the beginning of our lives, our caregivers make the best decisions possible on our behalf. A newborn is influenced by the environment that they are born in, and COVID-19 can impact that, whether they like it or not. So, how can the breastfeeding relationship thrive as we continue to battle the COVID-19 pandemic? 

Birth Practices

The goal is for labour to be as safe as possible for the birthing parent and the baby. No matter how delivery occurs, it is essential there is time for the baby and parent to bond, feel safe, and protected. Birth practices vary globally, and giving birth is intimate, personal, and remembered forever. Hospital and Birthing Center policies are intended to protect and maintain safety, but we have to carefully consider the impact of these practices. 

In March 2020, COVID-19 was declared a pandemic. Birthing parents were isolated without adequate labour support because of fear of transmission. Parents and newborns were separated if the parent was COVID-19 positive or suspected to have the virus. Hospitals and Birth Centers scrambled to change policies out of safety concerns. COVID-19 policies removed trusted support from the labouring person’s side and reduced their ability to be part of the overall decision-making process.

There are four tenets any parent needs to consider before giving birth: being able to know what to expect during labour and delivery, having trusted support persons in attendance, being cared for by skilled and competent caregivers, and being part of the decision-making process. So, what is essential to get breastfeeding off to the best start with COVID-19 around?

Golden Hour

The first moments of life set the tone for the next several days, weeks, and months. The Golden Hour is when a medically stable infant is placed on the birthing parents’ chest right after birth. Throughout Golden Hour, a newborn will self-regulate heart rate and respiratory rate and stay warm against a birth parents’ chest. The first feeding at the breast can also take place during this time. During the height of COVID-19, babies were separated from their birth parents if there was a confirmed or suspected diagnosis. 

If a parent is COVID-19 positive, an infant can still be placed on the birthing parent’s chest if the parent is well enough. Currently, the Centers for Disease Control and Prevention recommends being masked if an infant is placed skin-to-skin.The American Academy of Pediatrics recommends maintaining normal couplet care [parent-infant dyad] with confirmed or suspected COVID-19 status. However, policies are constantly changing given the evolving knowledge around COVID-19.

Breastfeeding

The current recommendations recognize the importance of providing human milk to infants during COVID-19. The World Health Organization’s current recommendation is to initiate breastfeeding no matter what the COVID-19 status is. The Centers for Disease Control and Prevention reports breastmilk is not likely to spread the virus to infants. If a lactating parent chooses to breastfeed, handwashing and wearing a mask is strongly recommended. 

Furthermore, if a parent chooses to provide pumped milk, a trusted caregiver should provide the pumped milk to the infant if the lactating parent is COVID-19 positive. Parents can also discuss options with caregivers about protective practices. These include having someone help to care for the infant if needed, rooming-in with the infant, using good handwashing, wearing a mask when providing care to the infant, and staying six feet away whenever possible.  

The possibility of transmitting COVID-19 through breastfeeding is uncertain. However, multiple studies such as ones by the American Academy of Pediatrics and Reproductive Health Journal suggest that the risk is low. The science also reveals that the benefits of breastfeeding outweigh the risk of not breastfeeding. Breast milk provides antibodies to protect a newborn against disease. The first feedings with colostrum establish the immune system, which is what protects the baby from the beginning well into childhood and ultimately adulthood. Colostrum contains the key immunologic components to establish the immune system and gut as it is rich in protein and nutrient-dense. 

The first feedings to the newborn are small. The newborn has a tummy the size of a cranberry for the first few days, so a teaspoon can be a full feeding on day one. By day three of life, the newborn has a tummy as big as a ping pong ball and can most likely take about an ounce in a feeding. A newborn does not eat on a schedule either, so one must watch for feeding cues. A newborn may eat 6 to 8 times on the first day and may want to eat 12 times on the second day. 

So, what can you do if a birthing parent needs to be separated from a newborn? Well, you can hand express or pump breastmilk. Even if you are COVID-19 positive, your colostrum and breastmilk are essential for a baby to have a good start. 

Conclusion

A nourished newborn sets the tone for the future. Providing colostrum and human milk to an infant can create a pathway to a healthy start. The journey may be different than planned, but having a solid start is possible, no matter the circumstances. Even with COVID-19, the breastfeeding relationship can thrive if you take the right steps. 

Experience with COVID-19 Vaccine While Pregnant

Authors: Negin Nia and Arrthy Thayaparan (Blog Coordinators)  | Interviewing: Dr. Cindy Barha, PhD, Department of Physical Therapy; Dr. Chelsea Elwood, PhD, Department of Obstetrics and Gynecology

Published: October 9th, 2021

To go along with our latest blog looking at research and effects of the COVID-19 vaccine on pregnant women, the Women’s Health Blog spoke to Dr. Cindy Barha to hear her personal experience with receiving the vaccine during pregnancy. 

While the information mentioned in this Q&A is the personal anecdote of Dr. Barha, everything mentioned has been verified and additional reading has been listed along with this blog. 

When did you decide to get your vaccine?

I got pregnant in September of last year, a few months after COVID had hit, and the first wave was just ending. I had already decided that I was going to get it as soon as I was eligible to get the vaccine. 

Why did you get vaccinated while pregnant? What was your thought process going into that?

I kept a close eye on data coming out of the United States and  the UK. They were the only countries at the time that I could find that were actually keeping track of COVID infections in pregnant women. Everything I’d seen was pointing towards  COVID symptoms being much more serious in pregnant women, compared to non-pregnant women of the same age. 

So if you were pregnant and got COVID, you’d be at higher risk for being hospitalized and being put on a ventilator, compared to a woman that was not pregnant and the same age as you. So that just kept coming up every time I looked to see if any new data had been published. 

As soon as I became eligible, and I had the opportunity in my second trimester, I jumped on it. I had no reservations about getting the vaccine. Nothing had come out in any of the studies I had seen to suggest that the vaccine was unsafe during pregnancy. I was always going to get the vaccine and I was actually really happy to receive it during my second trimester, because I was  really hopeful that Baby would receive some protection. And this is exactly what is being seen in more recent studies, COVID antibodies are found in umbilical cord blood!

Other than your research, who did you go to for advice on informing your decision?

I had two excellent OBs (obstetricians) at BC Women’s hospital, Dr. Chelsea Elwood is one of them and she is an infectious disease expert. I had a couple of conversations with her, I was curious what experts thought [about getting the vaccine, while pregnant].

Around the same time, I had a family member and a friend who were also pregnant, and were both skeptical about getting the vaccine. So, I shared my experiences and the knowledge that I’ve been able to gather from the data with them. But I also asked Dr. Elwood if she had anything to share that I could pass on to them and she pretty much echoed everything  I’d seen in studies looking at vaccine safety and efficacy. 

Did you have any side effects after the vaccine?

I had very few side effects. In fact, I think I only had a sore arm for maybe 12 hours, and I think that was because I slept on that side. But I didn’t get a fever, or any aches or pains. It was basically like getting the flu shot at that point for me, and I don’t normally get any side effects from that either. 

I mentioned this to Dr. Elwood and she told me about some data suggesting that women that are pregnant are suffering from less side effects from the COVID vaccine. My personal experience echoed what she was seeing in the data, that side effects seemed to be blunted in women that were getting their shots during pregnancy. I had the same experience from my second shot when I was breastfeeding. I had almost no side effects whatsoever. 

How did you feel about any effects to your baby?

When I got my first shot during my second trimester, researchers had just started to see that the antibodies that were being produced from mRNA vaccines were crossing the placenta. 

So Baby got some protection from my first shot. I got my second shot when i was about 3 months postpartum so Baby got antibodies from my second shot, as well through breastmilk. 

In a way this was a good sort of vaccine schedule for me, because the baby got antibodies through the placenta and through breastmilk. 

On a more cheerful note, how’s your baby now?

He’s great. He’s protected from COVID as far as I know. He’s four months old now and just living his life. 

Is there anything you would like to share to people who are or looking to get pregnant and trying to decide whether they should get the vaccine?

I think what I would say is, don’t think only about yourself, but also think about your baby. The vaccine has been given to over 6 billion people, and a portion of those people were pregnant. There’s been no negative outcomes in terms of pregnancy or fertility in any of these cases. 

So think about yourself, think about your baby. The vaccine is our best chance of getting through this pandemic. Without it, pregnant people are at a higher risk for being hospitalized, and that will potentially be harmful for your baby. 

The Women’s Health blog also reached out to Dr. Chelsea Elwood, a clinical assistant professor at the University of British Columbia in the department of Obstetrics and Gynecology, to hear her recommendations.

What is the recommendation right now?

So we recommend, in line with the Society of Obstetricians and Gynecologists of Canada, and a large number of other international bodies, that persons who are pregnant, persons who are breastfeeding, and anyone planning a pregnancy get the COVID-19 vaccine.

Is there a certain time period when women should receive the vaccine?

As soon as it’s available. So we recommend that at any time in pregnancy, first trimester, second trimester, third trimester, they should get the vaccine, including postpartum.

When it comes to the different vaccines, is one better than the others? Is mixing vaccines an issue?

We recommend any of the COVID-19 vaccines in pregnancy. There is currently more published data, generally on Pfizer and Moderna, although we are expecting much more data from the United Kingdom on AstraZeneca. There’s no safety signals related to pregnancy with any of those vaccines. So we actually recommend any of them.

The data around vaccine mixing is continuing to be studied and emerging. To be honest, at this point in time, we recommend any of them as long as patients are fully vaccinated and can’t make a preferential recommendation of vaccine mixing versus not in pregnancy.

With the talk about boosters, do you think pregnant women should be getting a booster shot?

At this point in time, there’s no data to suggest that pregnant women respond any differently than their non-pregnant counterparts. So a woman who is pregnant and has, for example, an autoimmune disorder and would normally qualify for a booster, then they should get their booster. Pregnancy, in and of itself, is not a reason at this point in time to get a booster. 

What do you have to say to folks worried about their babies and the vaccine?

Maternal vaccination for infant protection is a very well established modality to get babies protected from infectious diseases. We have traditionally seen that in the influenza vaccine, where moms are protected, babies are provided antibodies through placental transfer, as well as through breast milk afterwards.

We actually use maternal immunization for infant protection as a very good strategy to protect babies from whooping cough in the first couple of months after they’re born. And we recommend routinely the whooping cough vaccine in pregnancy for that reason. The COVID-19 vaccine is recommended primarily for maternal benefit. Meaning the outcomes that are being prevented by our mums getting COVID-19 vaccine, are ending up in the ICU hospitalized or having preterm birth by being vaccinated. 

Being vaccinated in pregnancy, and the degree of which that is going to protect the baby from COVID-19 has yet to be seen, because we simply don’t have enough data at that point in time. But we would expect it to be protective in the same way that any other vaccine in pregnancy does, in that it would confer some protection for babies after they are delivered and through breast milk.

What would you like to say to the folks deciding whether they should get vaccinated?

I’d encourage them to reach out to their maternity care provider and have that conversation. The Society of Obstetricians and Gynecologists of Canada and most of the provinces have great resources available to help patients and practitioners have the conversation. 

But again, we’re very clear about the recommendation because of the potential harm of COVID-19, the clear harm of COVID-19 if you get it in pregnancy, and the safety data we have now around vaccination in pregnancy. 

I would also discourage people around the social media that’s going around about the risk of infertility. There’s no data that the COVID-19 vaccine causes infertility. In fact, the studies actually oppose this. There’s no theoretical reason why the COVID-19 vaccines would cause infertility. And so we do recommend that people who are trying to get pregnant get fully vaccinated before they get pregnant, so that they’re protected during their pregnancy.

So we recommend again that persons who are pregnant, persons who are breastfeeding, and anyone planning a pregnancy get the COVID-19 vaccine.

Further Reading:

ACOG and SMFM Recommend COVID-19 Vaccination for Pregnant Individuals

SOGC Statement on COVID-19 Vaccination in Pregnancy

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

COVID-19 Vaccines While Pregnant or Breastfeeding

B.C. prioritizes pregnant people for COVID-19 vaccine and BC Children’s physician describes her immunization experience

COVID-19 Infection and Vaccination During Pregnancy

Authors: Jennifer Richard, PhD, Department of Psychology, UBC; Liisa Galea, PhD, WHRC Lead | Editors: Negin Nia and Arrthy Thayaparan (Blog Coordinators) 

Published: October 8th, 2021

Pregnancy is a vulnerable time for infection due to dynamic changes to the immune system leading to reduced immunity. This also implies an increased risk of people becoming severely sick after contracting COVID-19 (SARS-CoV-2) while pregnant. In fact, COVID-19 infection during pregnancy increases the risk of intensive care (ICU) transmission for the mother, preterm birth, caesarean (c-section) delivery, and admission to neonatal care for the baby. These risks are worsened by the Delta variant, currently the most common variant in Canada, which is up to twice as contagious as previous variants. The rise in Delta variant infections has increased the proportion of pregnant people with severe infection compared to previous variants. More specifically, Delta increases the risk of pregnant people requiring respiratory support, contracting pneumonia, and being admitted to intensive care. 

How can we protect pregnant people from COVID-19 infection and related complications?

The best protection, whether you’re pregnant or not, is getting vaccinated. However, the Center for Disease Control and Prevention (CDC) reported that only about 25 per cent of pregnant people in the U.S. have received at least one COVID-19 vaccine dose. Several studies have demonstrated that two doses of AstraZeneca-Oxford and Pfizer-BioNTech COVID-19 vaccines are still effective in preventing severe disease, hospitalization, and death, even against Delta. 

Recent studies suggest that two doses of these vaccines provide between 8895 per cent effectiveness in protecting against the Delta variant. Whether one dose of COVID-19 vaccine is sufficient to protect against Delta is inconclusive. One study reported barely detectable levels of neutralizing antibodies against Delta after one dose of vaccine. On the other hand, a Canadian paper, that has yet to be peer-reviewed, states that one dose of Pfizer-BioNTech, Moderna or AstraZeneca-Oxford provides “good to excellent protection against symptomatic infection and severe outcomes” against Alpha, Beta, Gamma and Delta variants. However, the study also reported reduced protection against Delta compared to the other variants. 

Vaccination is also recommended for individuals who have been infected by COVID-19.  The vaccination provides superior protection compared to previous infection by another COVID-19 variant.  So, despite the Delta variant affecting vaccine effectiveness, vaccinations still remain our best form of protection for severe illness, hospitalizations, and death. This is along with maintaining social distancing, masks, indoor ventilation, and hand hygiene. 

COVID-19 vaccine hesitancy and safety in pregnancy

Women tend to be more hesitant towards COVID-19 vaccination than men or gender diverse individuals, with pregnant people reporting an even lower intention of getting vaccinated. The greatest concerns of pregnant people regarding the vaccines are a lack of data on pregnancy safety regarding the vaccines and/or that the vaccine may be harmful for their baby. So what do we know about the safety of COVID-19 vaccines in pregnancy? Can it cause pregnancy loss, affect your chances of conceiving, or alter your genes or the genes of your baby?

Is it safe to get vaccinated against COVID-19 while pregnant?

Pregnant people weren’t included in the initial COVID-19 vaccine trials. However, over 156,000 pregnant people have now been vaccinated with Pfizer-BioNTech or Moderna vaccines in the U.S. with no raised safety concerns. More specifically, the risks for adverse effects relating to pregnancy, including pregnancy loss, birth defects or effects on birth weight, were the same, or lower, than risks reported prior to the pandemic. 

Importantly, while the risk of preterm birth was not increased after vaccination against COVID-19, this risk was increased in non-vaccinated pregnant people infected by the COVID-19 virus. As for the more immediate side effects after vaccination, pregnant people reported having a slightly sorer arm (around the injection site). But otherwise, pregnant people actually reported having milder side effects than non-pregnant people, for side effects such as headaches, muscle soreness and fever. 

But are COVID-19 vaccines effective in pregnant people?

Although pregnancy causes changes to your immune system, COVID-19 vaccination in pregnant and lactating people provides the same level of immunity against the COVID-19 virus compared to vaccination in non-pregnant people. The level of protection is equal across all three trimesters, as vaccination during the first, second and third trimester gives rise to the same level of antibodies produced against COVID-19. In addition, the level of protection in all vaccinated individuals (non-pregnant, pregnant and lactating) was higher than levels observed in pregnant people who had previously been infected by the COVID-19 virus, indicating that even those who have previously been infected by COVID-19 should get vaccinated.

Can COVID-19 vaccines affect your risk of becoming pregnant?

There is no evidence that vaccination against COVID-19 would affect fertility. In males, COVID-19 vaccination does not result in a reduction in semen volume, sperm concentration or motility. In females, embryo implantation rates were the same as in non-vaccinated individuals. In addition, COVID-19 vaccines can not reach or cross the placenta, they act in the muscle where the vaccine is given. And even if the vaccines could reach the placenta, they can not induce antibodies against, affect or injure the placenta. However, placentas from people who tested positive against the COVID-19 virus during pregnancy showed abnormal blood flow between mother and baby. These data indicate that vaccination during pregnancy is safer than getting infected with COVID-19 during pregnancy. 

Since the vaccine rollout, thousands of individuals included in the V-safe Pregnancy Registry have reported becoming pregnant after vaccination. In addition, the rate of accidental pregnancies in vaccinated and unvaccinated individuals were reported at equal levels — showing that vaccines don’t impact pregnancy.

Can the vaccines alter your DNA or the DNA of your baby? 

No, vaccines cannot alter your DNA. Pfizer-BioNTech and Moderna are the two most common COVID-19 vaccines given to pregnant people. They are referred to as mRNA vaccines, which carry information (mRNA) to make a part of the COVID-19 virus (spike protein). They can only make a part of the virus, and not the complete virus. The components of the vaccine can’t cause infection in the mother or baby. Neither can they alter your DNA, or the DNA of your baby (mRNA does not alter DNA). The vaccines don’t contain DNA and human cells don’t have the ability to transform RNA to DNA, only the other way around. Therefore, these vaccines are not able to integrate into your DNA, or the DNA of your baby, or cause long-term genetic changes. As an aside – if we could change DNA with mRNA we would already have cures for genetic illnesses such as cystic fibrous or Huntington’s disease.

Can vaccination benefit your baby?

The vaccine provides protection to the baby in the womb indirectly, by lowering the risk of severe sickness in the mother. In addition, COVID-19 vaccination can directly protect your unborn and/or newborn baby, because protective antibodies against COVID-19 cross the placenta, and provide protection against COVID-19 to the baby at birth. In addition, COVID-19-specific antibodies have been found in the umbilical cord of babies, and breast milk, of mothers who were vaccinated during pregnancy. 

While cases in babies and small children reported so far have been uncommon, and often cause mild to moderate symptoms, the Delta variant has proven to be more harmful to children. In the U.S., COVID-19 hospitalization rates in children and adolescents increased nearly 5-fold in late summer, a time in which Delta has been the predominant circulating variant. In a recent study from Israel, over 10 per cent  of children who were diagnosed with COVID-19 reported symptoms of long COVID, such as continued illness, fatigue or breathlessness. In addition, 30 per cent of parents of affected children reported a decline in “neurological, cognitive, and mental health abilities” compared to prior to COVID-19 infection, for example disturbed sleep and concentration problems. Furthermore, we do not yet know potential long-term effects on children whose mothers were infected while pregnant. Although rare, there are a few cases of newborns born to COVID-19 positive mothers that were tested positive for the virus at birth.This indicates that transmission of COVID-19 from mother to child during pregnancy is possible. Furthermore, the fetus can still be affected by stress, restricted oxygen, reduced placental function and sickness in the mother infected by COVID-19, in addition to the increased risk of preterm birth and c-section delivery.

Taken together, the vaccines provide great protection against symptomatic infection and severe outcomes. Recent data indicates that you are almost 30 times more likely to end up in the ICU if you are unvaccinated. Furthermore, vaccination against COVID-19 during pregnancy is effective, and far safer than the risk of contracting the virus itself, which, while rare, has a 15 times greater risk of death during pregnancy. Vaccination during pregnancy can also benefit the baby by protecting them from indirect effects of disease in the mother, and by providing antibodies against COVID-19. Not to mention it will protect you after giving birth and protect your community. The data overwhelmingly support vaccination during pregnancy as safe and effective. 

So, the bottom line is: if pregnant people are concerned about their safety or the safety of their unborn child, getting the shots (of COVID-19 vaccine) is their best shot.

Feature image by Dr. Jennifer Richard

COVID-19 Differences Between Men and Women

Authors: Maria Tokuyama, PhD, Assistant Professor at UBC Microbiology & Immunology; Joshua Mao, University of California Berkeley, Summer Intern at the Tokuyama Lab, UBC Microbiology & Immunology | Editors: Negin Nia and Arrthy Thayaparan (Blog Coordinators) 

Published: September 10th, 2021

Since March 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has drastically changed our lives and has killed over four million people worldwide. Although people of all ages and sex get COVID-19, a striking observation is that the number of female COVID-19 deaths were half of what was seen in males. Data analysis from New York City Health found that of all death cases 38.2% were female and 61.8% were male. So what are the factors that contribute to this sex difference in COVID-19 outcomes? Several research studies have shown that differences in immune response and metabolism during disease may partly explain the worse outcomes in males than females. Here, we will summarize the key takeaways from those studies. 

The immune system is largely divided into two parts: the innate and adaptive immune system. The innate immune system is the body’s first line of defence against infection. It is able to recognize danger within minutes and rapidly fire inflammatory factors called cytokines and chemokines to recruit immune cells to sites of infection and set off alarms to engage the adaptive immune system. The adaptive immune response takes about five to seven days to fully kick-in, but once activated, it is very specific to the invading pathogen and provides long-term memory responses that can be quickly recalled to fight future infections by the same pathogen. The adaptive arm of the immune system is what is provided by vaccinations. During viral infection, both the innate and adaptive immune responses work together to fight the infection. Ultimately, the magnitude and quality of the immune response dictate disease outcomes. 

Male patients show increased activation of the innate immune response.

In a study published by Yale in August 2020, researchers compared immune responses between female and male hospitalized COVID-19 patients, who were not taking anti-inflammatory drugs. They found that male patients had higher amounts of key inflammatory molecules, interleukin 8 (IL-8) and 18 (IL-18), in their blood compared to female patients, despite having similar amounts of SARS-CoV-2 RNA. In addition, male patients had a higher amount of a type of innate immune cells called non-classical monocytes. These findings are supported by another study that reported worsening health conditions in males due to SARS-CoV-2 infection was related to increased innate immune activation. Although the immune response is intended to fight the infection, over activation of the innate immune response can lead to tissue damage and may be one explanation for why males have worse outcomes than females in COVID-19.  

Female patients have a stronger adaptive immune response.  

The two major players of the adaptive immune responses are B cells and T cells. B cells make virus-specific antibodies that bind to the virus and prevent the virus from infecting cells. T cells recognize cells that are infected and destroy them to prevent further spread of the virus. T cells also help B cells make more antibodies and strengthen the immune response. 

From the same Yale study, researchers found no difference in the amount of antibodies against SARS-CoV-2 between male and female COVID-19 hospitalized patients. However, female patients had a higher amount of fully activated T cells than males. This means that female patients are better able to control the infection through their T cells, and the weaker T cell response in males may be another reason for worse outcomes with COVID-19. 

Kynurenic acid levels correlate with deteriorating disease in males. 

The metabolism regulates the immune system through metabolites, which are small molecules that are produced through chemical reactions in the body. A study published in July 2021 found that a higher amount of a key metabolite called kynurenic acid (KA) produced from kynurenine was related to higher innate immune responses in both female and male COVID-19 patients, but this association was more pronounced in males. Male patients with worse COVID-19 had a higher ratio of kynurenic acid to kynurenine (KA:K), which also seemed to predict higher innate immune responses and lower amounts of activated T cells. A higher Body Mass Index and increased age were associated with worsening disease in male COVID-19 patients. Overall, the metabolic status of individuals seems to contribute to disease outcomes, where certain amounts of KA predicted over activation of the innate immune response and worse disease in males. 

Different levels of sex hormones in COVID-19 patients.

Estradiol and estrone are major and minor female sex hormones, and testosterone is a major male sex hormone. Sex hormones can affect many aspects of the immune system and are important to consider. A preprint article, that has not yet been peer-reviewed, reported that both male and female COVID-19 patients have higher levels of estradiol and estrone compared to healthy individuals. However, only male COVID-19 patients had decreased testosterone levels. Whether lower testosterone levels in male patients results in worse disease is not known, but it will be an important factor to monitor moving forward.     

Concluding remarks:

A wide range of disease outcomes have been observed in COVID-19 including a major difference between males and females. These studies highlight key sex differences in SARS-CoV-2 infection that affect severity of COVID-19 including differences in the coordination between the innate and adaptive immune response, metabolism and potentially, sex hormones. These differences between sexes may be important factors that explain why fewer females have died from COVID-19 than males.  

Bibliography

“Worldometer Coronavirus Death Toll.” Worldometer, 2020, https://www.worldometers.info/coronavirus/coronavirus-death-toll/. (Accessed 1 August 2021).

Takahashi, Takehiro et al. “Sex differences in immune responses that underlie COVID-19 disease outcomes.” Nature. 2020 Dec;588(7837):315-320.

Petrey, Aaron C, et al. “Summary of Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.” J Leukoc Biol. 2021 Jan;109(1):55-56. 

Cai, Yuping, et al. “Kynurenic acid may underlie sex-specific immune responses to COVID-19.” Sci Signal. 2021 Jul 6;14(690):eabf8483.

Schroeder, Maria, et al. “Sex hormone and metabolic dysregulation are associated with critical illness in male Covid-19 patients.” MedRxiv, 2020, https://www.medrxiv.org/content/10.1101/2020.05.07.20073817. (Accessed September 2021).

 

 

COVID-19 Vaccines and Infertility: Fact or Fiction?

Authors: Alex Lukey, RN, WHRC Blog Co-coordinator; Arrthy Thayaparan, BSc, WHRC Blog Co-coordinator; Liisa Galea, PhD, WHRC Lead; Deborah M. Money, M.D., F.R.C.S.C.

Published: July 2nd, 2021

It can be difficult to separate fact from fiction when it comes to COVID-19 vaccines, particularly in relation to fertility and reproductive health. This blog will dive into the scientific findings of these claims and bust some of the many myths circulating about the vaccines’ impact on fertility. 

Myth #1: The vaccines haven’t been tested for pregnant people or those trying to conceive

In the earlier stages of vaccine trials, people who are pregnant or trying to conceive are not included for safety. However, in large trials, such as those for the COVID-19 vaccines, there are often accidental pregnancies. While not initially planned, this data provides a natural fertility experiment.

In a paper published by Nature, “Are COVID-19 vaccines safe in pregnancy?” the control groups had 28 accidental pregnancies, and the vaccinated groups had 29 pregnancies. The vaccinated groups received Pfizer/BioNTech, Moderna and AstraZeneca vaccines in these trials.

If the COVID-19 vaccine decreased fertility, there would be fewer accidental pregnancies in the vaccinated groups than the control groups. But it turns out the chances of pregnancy were the same. Since accidental pregnancy rates were similar between groups, there is no evidence that COVID-19 vaccines decrease a person’s fertility. The problem here is that the numbers in this comparison are not sufficient to state that there is no impact, but there is no biological reason to suspect that there would be an impact and no data to support this claim.

Myth #2: The COVID-19 vaccines cause miscarriages

Not only were there no differences in the numbers of conceptions in the vaccine trials, but there was also no difference in the number of miscarriages between participants in the control and vaccinated groups.

Based on the latest research, there is no reason to believe that the COVID-19 vaccine could increase the risk of a miscarriage.

Myth #3: The COVID-19 vaccine damages the placenta

This myth is false–it rests on the belief that after receiving the COVID-19 vaccine, the body’s immune system might attack syncytin-1, a key protein necessary for the placenta’s formation. There is also the claim that the spike protein of the COVID-19 virus and syncytin-1 are so similar that the immune system might mistake one for the other. 

This claim was tested in a recent study that showed no immune cross-reaction between the spike protein and syncytin-1, dispelling the claim that there is a risk of placental injury after taking the COVID-19 vaccines.

Myth #4: mRNA vaccine technology hasn’t been tested long enough to know if it causes infertility

While mRNA is a new technology compared to other vaccine delivery methods, there have been numerous human trials using mRNA vaccines for Influenza, HIV-1, Zika, Ebola and rabies virus well before the COVID-19 pandemic.

In fact, the first human trial of an mRNA vaccine began in 2006, giving researchers almost 15 years of follow-up data. There has been no evidence suggesting long-term fertility concerns arising from the use of mRNA vaccines based on current research. 

Myth #5: mRNA vaccines change your DNA and could impact fertility

To impact DNA, a substance must enter the nucleus, or control centre, of the cell, where DNA is stored. mRNA from vaccines is not able to enter the nucleus and therefore cannot impact DNA. 

Rather, the body uses mRNA as a template to create proteins that teach the body how to fight the COVID-19 virus. 

Take-Aways

The known risks of COVID-19 to pregnant people are severe, including increased rates of intensive care admissions and more premature births. In weighing these risks alongside the latest research, professional associations are making a strong recommendation for people planning a pregnancy to receive the vaccine.

As stated by the Canadian Society of Obstetrics and Gynecology: “There is absolutely no evidence, and no theoretic reason to suspect that the COVID-19 vaccine could impair male or female fertility. These rumors are unfounded and harmful.”

The evidence is clear. The best thing to do to protect your health and the health of those around you is to get vaccinated as early as possible. 

Menstrual Irregularities and the COVID-19 Vaccine

Authors: Romina Garcia de Leon, Neuroscience MSc student, Faculty of Medicine, UBCJennifer Richard, PhD, Department of Psychology, UBC;  Liisa Galea, PhD, WHRC Lead | Editors: Alex Lukey and Arrthy Thayaparan (Blog Coordinators) 

Published: June 18th, 2021

“Imagine if you didn’t know that fever could be a vaccine side effect? You might be concerned that something untoward was happening to your body when all you were experiencing was a typical post vaccine fever. That is exactly the same with menstrual irregularities.” (Gunter, 2021).

There is a growing concern that the COVID-19 vaccine is causing disruptions to menstrual cycles and questions as to why the vaccine may have this effect have been raised by women awaiting their vaccines. Valid, as these questions are, we have few answers as there has been very little to no research in this area. In fact, most of these concerns have been reported through social media and voluntary self-report on databases such as the United States’ Vaccine Adverse Event Reporting System (VAERS) and the Canada Vigilance Adverse Reaction Online Database.

Yet, to date, there have been no systemic studies to examine whether the COVID-19 vaccine – or other factors – are causing these irregularities. So, short of an actual study to show that there is any effect of the COVID-19 vaccine on menstrual cycles, what can we infer?

Unfortunately, given the dearth of research into women’s health, it is not altogether surprising that we do not have this information at the ready. Studies looking at females alone make up only about 6% of the literature. Male-only studies make up approximately 40% of the total studies, although the total number varies by discipline. Women’s health includes studies that would examine how hormonal contraceptives influence mood, or how menopause influences memory in middle age or – you guessed it – how vaccines affect the menstrual cycle or even whether there is a time during your menstrual cycle that the vaccine could cause the fewest side effects. The disparity in women’s health research is no exception in COVID-19 literature.

Thus far, studies examining the main receptor that SARS-CoV-2 binds to in order to enter cells, and infect the body, angiotensin-converting enzyme 2 (ACE2), have been predominantly conducted in males. In fact, a recent study showed the extent of the disparity with 70% of the research conducted involving male-only studies, and only 11% involving females. As a result, it is not surprising that we know so little about how COVID-19 or the COVID-19 vaccines may affect menstrual or menopausal symptoms.

Certainly, many people will already be aware that menstrual cycle variations occur naturally (with more regular cycling often achieved through taking steps to control the menstrual cycle – e.g. taking hormonal contraceptives) and that menopausal symptoms can vary dramatically. Generally, cycle lengths vary in the general population because of many factors including biological and environmental factors. So, with this in mind, what science is there to show what we might expect post-COVID-19 vaccination?

Plausible Theories 

A recent study showed that COVID-19 infection itself influences menstruation. Specifically, a research group in China analyzed data from 177 menstruating people diagnosed with COVID-19, and found that a quarter of all participants had a change in menstrual pattern. In this study, researchers identified that nearly all participants returned to their normal menstrual pattern 1 to 2 months following their COVID-19 diagnosis. However, based on these findings, it is clear that further research is also needed to investigate whether the COVID-19 vaccine also affects menstruation.

In the meantime, there are theories that may provide insight into what may be happening to the menstrual cycle, and why, in response to COVID-19 vaccination.  But before we begin it is important to acknowledge that the entire female reproductive tract (vagina, cervix, uterus, endometrium) is a system that responds to immune challenges (think yeast infections and pelvic inflammatory disease) but this system also needs to show immune tolerance (as is the case in pregnancy – the fetus is a foreign body that we don’t want the body to reject). It shouldn’t surprise us that some changes occur in the reproductive tract when the immune system is challenged…like with infections or vaccine stimulations.

Environmental: Stress

Stress itself can challenge our immune system. A stress response, much like a foreign body, can cause an immune response (and this makes perfect sense from an evolutionary perspective as stress and infection were often seen together!) In doing so, disruptions to our menstrual cycle and menopausal status may occur with stress. Throughout the COVID-19 pandemic, many of us have undoubtedly experienced higher levels of stress. Moreover, women around the world have reported a disproportionate amount of stress, compared to men, for example, due to the added challenges imposed by school closures and daycare closures. If women have been reporting high-stress levels – and a lot of stress can affect the menstrual cycle – is the stress of the pandemic resulting in abnormal periods?

In May 2020, a research group analyzed data from 263 participants and found that an increase in COVID-19 pandemic-related stress was correlated with an increase in menstrual irregularities. Similarly, preliminary data from Canada showed that 27.8% of women experienced menstrual irregularities after receiving the COVID-19 vaccine (unpublished data). This leads us to question whether the changes seen in menstruation are an indirect result of higher levels of stress due to the ongoing pandemic or a direct response to vaccination, or perhaps a combination of the two!?

Biological: A direct link

Vaccines (for example, against rubella) can trigger menstrual irregularities depending on what stage it is received during the menstrual cycle. The endometrium, which is the lining of the uterus, is part of the immune system. This complex reproductive organ is host to a multitude of immune cells and offers protection from infections. These immune cells also vary cyclically, according to the phase of the menstrual cycle. This makes sense: the lining of the uterus sheds tissue which results in menstrual bleeding (and builds tissue too). It may be that when an immune response is mounted post-vaccination, the endometrium reacts by adapting its immune environment to protect the uterus. This abrupt change may trigger abnormal menstrual changes such as an increase (or decrease) in menstrual length and blood volume. 

Interestingly, the ACE2 receptors involved in COVID-19 infection are found on the reproductive tract – including the endometrium and ovaries. The presence of this receptor in the ovaries modulates the production of sex hormones, estradiol and progesterone, which in turn can increase or decrease cells on the endometrium. If this theory checks out, does the time the vaccine is administered during one’s cycle change the probability of having menstrual irregularities? A research group in Spain looked at just this. They found that ACE2 receptors increase in the endometrium during the luteal phase (the time between ovulation and the start of menstruation), suggesting a higher risk for viral infection during this time. Meaning that menstrual side effects may be dependent on cycle stage at the time of vaccine administration. But until this is examined and tested in a research setting, this will remain simply a theory.

The COVID-19 Vaccine and Post-menopausal symptoms

What about people reporting bleeding after menopause?

Just like there is a lack of research into the impact of COVID-19 infection/vaccination on menstruation, even less is known about how this may affect post-menopausal women. Could the vaccine or infection be directly impacting the reproductive system? Recently, post-menopausal women have taken to social media to report abnormal bleeding following a COVID-19 infection or vaccination. Although there are reductions in some immune cells in the endometrium post-menopause, immune cells are still reactive across the reproductive tract. There is, however, a scarcity of research on this subject.

Although we do not yet know if COVID-19 vaccines are the cause of the reported incidents of post-menopausal bleeding, there may be several other reasons for bleeding to occur, such as hormone therapy or medication-related changes in the endometrium.  Regardless, risk of postmenopausal bleeding after vaccination seems to be low as it was not reported in initial trials, and few incidents have been reported so far (27 cases of postmenopausal hemorrhage have been reported in VAERS) with about 50% of women (almost 83 million!) in the USA already having received at least one vaccine against COVID-19. It should, however, be noted that this is a voluntary self-report system for recording adverse events and it is unclear whether all women would consider post-menopausal bleeding as a vaccine-related event.

Is there a direct link to the female reproductive system through ACE2 receptors in menopause as well?

Considering that knowledge on immune changes during pre-menopause is still growing, information about the levels of ACE2 receptors (reminder, these are the receptors that allow for COVID-19 infection) in the endometrium post-menopause is unknown. However ACE2 receptors are linked to levels of estrogens so it may not be surprising that menopausal status is related to COVID-19 outcomes, with postmenopausal people having more severe outcomes compared to pre-menopause. Intriguingly, women over 50 that receive hormone therapy are at reduced risk of mortality due to COVID-19. ACE2 receptors are found in numerous tissues and the distribution of these receptors does change with age in females in the heart and possibly lung, but there are few studies in this area. However, the potential connections between COVID-19 vaccination and effects on the endometrial immune system, and ACE2, will require further study. But it is important to recognize that the female reproductive tract is actively involved in immune challenges even post-menopause.  

Let’s get vaccinated!  

In sum, we know very little of the side effects of any vaccine, let alone the current vaccines available for COVID-19, on menstruating and post-menopausal women. Yet, we know for sure that these risks are far smaller than the risk of becoming severely ill from COVID-19 itself. Although the risk of mortality from COVID-19 is higher in males, the incidence of COVID-19 infection is actually higher in females and although it needs more study, long-haul COVID symptoms (those that last post infection) is more common in women than in men. That’s why more than ever it is important to be vaccinated.

The bottom line as we see it: There is no evidence that the COVID-19 vaccine alters menstruation or menopause long-term. Whether COVID-19 vaccination is behind the reported cases of postmenopausal bleeding, or menstrual changes, remains to be investigated. And this again highlights the need for additional research on women’s health, in general. For example, had there been more concerted research efforts examining menstruation and menopausal physiology, the current issue of possible vaccine side effects may have been avoided (or at least better understood!). As a whole, however, the take-home message is that although there may be potential side effects on menstruation and menopausal status as a result of the COVID-19 vaccine, these, like other vaccine side effects, appear to be temporary. It is therefore important to follow health guidelines and get vaccinated as soon as possible.

If you are interested in participating in a study, Dr. Kate Clancy at the University of Illinois has a survey open documenting any menstrual cycle abnormalities following the vaccine: https://redcap.healthinstitute.illinois.edu/surveys/index.php?s=LL8TKKC8DP 

More reading? – Check out these blogs on the COVID-19 vaccine and menstrual irregularities or bleeding post menopause by Jen Gunter.

 

 

 

 

 

 

 

Behind the Frontlines for World Health Day

Author: Alex Lukey, Women’s Health Blog Co-Coordinator | Editors: Arrthy Thayaparan, Women’s Health Blog Co-Coordinator

Published: April 7th, 2021

This past year will go down in history as the year the world halted at the hands of a global pandemic. But the sacrifice and dedication from our frontline workers, kept hopes up and fears at bay throughout these unprecedented times. For World Health Day, our blog co-coordinator Alex Lukey sat down with two nurses, Krista Koenig and Lauren Dyck, working on the frontlines of COVID-19 hospital floors to talk about the past year.

The Beginning

Alex: Take me back to this time last year. What were those first few months like for you?

Krista: The first few weeks were kind of chaos. Nobody was sleeping well. We were all on edge, trying to figure out what was going to happen.

Lauren: I remember thinking to myself, I’ve only been out of school for two years. How do I deal with this? Even the people supporting us didn’t know what to do, so it was very confusing and scary.

Lauren: Every time we discharged a patient, another one would come through the door. It’s kind of what it is like right now actually too. Last spring, we were never over capacity, but we are now. We’ve got a couple of variants on my unit, and now it’s younger people coming in. Really, really sick people, so it’s a lot to deal with for sure. We’re all so burnt out trying to deal with the workload and then trying to deal with the deaths on top of it too.

The Hardest Part

Krista: I’ve never had trouble sleeping before this. That’s kind of where it translated for me. I didn’t see my family. I was just so scared of bringing it to somebody that I loved. Even though my family all lives here in town, I couldn’t see them.

Lauren: The mental health aspect of not for myself but for the patients. A lot of them, when they come to the hospital and are that sick, they’re here for a good three weeks.

Both Lauren and Krista spoke about the difficulty of supporting patients near the end of their lives. While many of the sickest COVID-19 patients are cared for in the intensive care unit (ICU), many long-term care home residents do not go to the ICU. These older adults may choose to forgo life-saving measures such as intubation. So, while nurses in the ICU dealt with many deaths from COVID-19, the brunt of deaths from long-term care homes fell on the shoulders of nurses working on lower acuity COVID-19 units, such as Lauren and Krista.

Lauren: There’s a lot of struggling at the end because you can’t breathe.  At the beginning, we weren’t even allowed visitors for people who were dying, so we’d have to zoom with their families. We would have to help them say goodbye like that which is just horrible. Now we do visits for some people, but some families are scared to come in, which I understand. But you can’t fix that emotional part of it. It’s hard to feel like you can’t really do anything about it.

Krista: Family members haven’t been able to visit unless somebody is critically ill or near death. I think that’s been one of the most significant changes for me too. In my practice, it’s so much centered around family care and including everybody.

Who is Caring?

Despite personal protective equipment (PPE), nurses are at a high risk of contracting the virus on the job. A report published by BC Women’s Foundation found that 80% of people working in healthcare are women in BC. Further, the roles with the highest risk of exposure due to close physical contact are professions that have higher numbers of women, such as nurses and personal care aides.

Krista: We did have nurses end up testing positive on our floors.  We were nursing our own nurses.

COVID-19 also presented women starting families with a difficult decision. While there is much more research needed, there was almost no information on the risks of COVID-19 for pregnant women a year ago. This lack of data continues to be a cause of significant concern for women.

Krista: We have so many pregnant nurses that we were trying to protect. We have such a strong solid group that we just try to look out for each other. We tried to give the positive patients to younger healthy nurses.

Hope

Both Krista and Lauren spoke about how access to the vaccine is giving them hope for the future.

Krista: It’s a big moment for science and history for everyone. Unfortunately, there’s still so much fear and miscommunication in this information and media right now about vaccines, but for our group that was such a turning point.

Lauren: When I got vaccinated, it was a very emotional moment for me. I actually almost cried because I was thinking, we’re gonna get through this. It’s almost like a race right now with our numbers going up and trying to vaccinate as many people as possible.

 

 

Meet the Nurses

Krista Koenig

Cardiac Medical RN

Asthmatic Frontline Worker

Vaccinated

 

 

Lauren Dyck

Lauren grew up in Vernon, BC, and completed her nursing degree at UBCO in Kelowna in 2018. After graduating, she moved to Vancouver and has since been working at Richmond Hospital on a cardiac/covid-19 ward. She will be starting a new job in May on the cardiac unit at Vancouver General Hospital. She hopes to pursue travel/ER nursing in the future.

 

 

The Pandemic is Taking Women’s Breath Away: Intimate Partner Violence and Strangulation on the Rise During COVID-19

Author: Karen Mason, Co-founder of SOAR (Supporting Survivors of Abuse and Brain Injury through Research) | Editors: Alex Lukey and Arrthy Thayaparan (Blog Coordinators) 

Published: November 25th, 2020

Since Covid-19 and its lockdowns first threw a giant wrench in our collective lives more than eight months ago, news headlines around the world have echoed a similar theme. 

“Calls to Canadian domestic violence helplines jump during pandemic”

“Minister says COVID-19 is empowering domestic violence abusers as rates rise in parts of Canada”

“A New Covid-19 Crisis: Domestic Abuse Rises Worldwide”

Whether it’s CBC, the Canadian Press, or the New York Times, the message is clear and unequivocal: The pandemic has created ideal conditions for intimate partner violence and abuse to thrive. Vulnerable victims are trapped at home with their abusers, making it harder than ever to access help and safety.

Intimate partner violence and abuse already affect one in three women around the globe. In Canada, a woman is killed by her intimate partner every six days, and Canadians spend more than $7.4 billion in tax dollars every year on the consequences of intimate partner violence.

While the pandemic can’t be blamed for  intimate partner violence, it has absolutely played a major contributing role in worsening this existing public health emergency. Indeed, UN Women, the United Nations entity dedicated to gender equality and the empowerment of women, has called violence against women the “shadow pandemic” of the Covid-19 crisis.

This past summer, the Ending Violence Association of Canada and Anova surveyed 376 staff and volunteers in the gender-based violence sector. The resulting report “Pandemic Meets Pandemic: Understanding the Impacts of Covid-19 on Gender-Based Violence Service Provision” found that 82% of workers described “an increase in prevalence and severity of violence.”[1] Comments from the survey also referenced a dramatic increase in reports of strangulation. 

Strangulation is an extremely common, and dangerous, form of intimate partner violence. It is widely known as the most lethal form of intimate partner violence, which happens in roughly half of all cases, and can cause brain injury or death within minutes.[3] In fact, women who are strangled are 750 times more likely to be killed in a subsequent assault.[4] It’s a shocking and highly troubling fact of which most survivors, and indeed, many of those who work on the frontlines to support them, are not even aware.

The increase in violence, and strangulation in particular,  is even more alarming given the findings from a small, but steadily growing, body of research. Recent studies have shown as many as 92% of women who experience intimate partner violence may also experience a brain injury. [2] 

 

 

Given the shame and stigma still associated with intimate partner violence, many victims are reluctant to report it. That fact, combined with an ongoing lack of education on the intersection of intimate partner violence with brain injury, means many of these injuries go undiagnosed and untreated.

What can we do? 

In a bluntly worded commentary in the Canadian Medical Association Journal, several authors said when it comes to health care providers the answer to that question is “more”.[5]

The piece stated those who work with women in health care settings “frequently” encounter victims of partner violence. Yet only 14% of patients, who clearly had intimate partner violence-related injuries, were questioned specifically about the issue or their need for support.

The article went on to add “health care providers, although facing the need to learn many new skills related to COVID-19, must also maintain awareness of IPV, seek opportunities for self-education, develop strategies for discussing IPV and become familiar with currently available local resources for patient referral.”[5]

Recognizing the true scope of intimate partner violence, and of strangulation as a highly lethal aspect of it, must be part of that effort. For those who work in health care, that means learning how to look for key signs and symptoms. 

Women who’ve been strangled may have:

  • Raspy voice
  • Trouble swallowing/breathing
  • Ringing in the ears
  • Red spots in eyes or on skin
  • Scratches/bruising on neck
  • Loss of memory
  • No visible signs or symptoms! It’s important to note strangulation can often cause unseen internal injury that can lead to death, even months after an incident.

Women who’ve experienced brain injury as a result of intimate partner violence may report:

  • Trouble sleeping
  • Fatigue
  • Dizziness
  • Headaches
  • Worries and fears
  • Depression
  • Sensitivity to noise and light
  • Memory issues
  • Difficulty concentrating
  • Trouble managing emotional responses

But what about those among us who aren’t medical professionals? What can we do when faced with the possibility a friend, co-worker, or family member may be experiencing intimate partner violence?

Educate Yourself

Learning about the Cycle of Abuse, which outlines the pattern of how violence escalates and explodes, is a good way to educate yourself. 

 

 

While the cycle can occur over the course of hours, days, weeks, or months, it’s typically the same.Becoming familiar with the signs of abuse you might notice is another great way to get educated.

Victims may:

  • Have bruises, scratches or other unexplained injuries.
  • Seem anxious, uncomfortable or afraid around their partner.
  • Withdraw and make excuses not to spend time with family and friends.
  • Seem to have little access to money or other resources.
  • Wear clothing such as pants and long-sleeved shirts, even in summertime.
  • Get frequent calls or texts from their partner and display a need to check in often.
  • Make excuses for their partner’s bad behaviour

Listen and support

One of the key things any of us can do when it comes to interacting with survivors of intimate partner violence is to listen and provide support. Be a non-judgmental, confidential ear, and consider saying things such as:

  •  “You didn’t deserve this. It’s not your fault.”
  • “I’m sorry this happened to you.”
  • “I’m concerned about you.”
  • “How can I help?”
  • “It sounds like you’re doing the best you can.”
  • “I’m here to listen.”

Women who receive positive responses tend to recover more quickly. They are even more likely to work with the authorities, access safety supports, and report future instances of violence.

Refer

If you know someone who is experiencing abuse, and they’re ready to leave the relationship or otherwise seek help, there are countless free, confidential resources to which you can point them, including Sheltersafe. This clickable, online map resource from Women’s Shelters Canada connects women to the nearest shelter, where they can find safe refuge, and the counselling and other supports they need to transition into a life free of abuse.

With the second wave of the pandemic upon us, and new lockdowns already underway or looming, it’s clear the risk to victims of intimate partner violence is far from over. And while this November 25th marks an important opportunity to highlight the issue through the International Day for the Elimination of Violence Against Women and the start of  16 Days of Activism against Gender-Based Violence, we must remain vigilant in the months and year still to come if we are to have any hope of beating the shadow pandemic.

 

Karen Mason is an advocate for women survivors of intimate partner violence, and is co-founder and director of community practice for SOAR (Supporting Survivors of Abuse and Brain Injury through Research). All figures have been provided for by SOAR.

 

References

1. Trudell, A.L. & Whitmore, E. (2020). Pandemic meets Pandemic: Understanding the Impacts of COVID- 19 on Gender-Based Violence Services and Survivors in Canada. Ottawa & London, ON: Ending Violence Association of Canada & Anova. https://endingviolencecanada.org/wp-content/uploads/2020/08/FINAL.pdf

2. St Ivany, A., & Schminkey, D. (2016). Intimate Partner Violence and Traumatic Brain Injury: State of the Science and Next Steps. Family & community health, 39(2), 129–137. https://doi.org/10.1097/FCH.0000000000000094

3. Strack, G. B., & Gwinn, C. (2011). On the Edge of Homicide: Strangulation as a Prelude. Criminal Justice, 26(3), fall. Retrieved from https://www.familyjusticecenter.org/wp-content/uploads/2020/09/On-the-Edge-of-Homicide-Strangulation-as-a-Prelude-Strack-and-Gwinn-2011.pdf.

4. Glass, N., Laughon, K., Campbell, J., Block, C. R., Hanson, G., Sharps, P. W., & Taliaferro, E. (2008). Non-fatal strangulation is an important risk factor for homicide of women. The Journal of emergency medicine, 35(3), 329–335. https://doi.org/10.1016/j.jemermed.2007.02.065

5. Bradley, N. L., Dipasquale, A. M., Dillabough, K., & Schneider, P. S. (2020). Health care practitioners’ responsibility to address intimate partner violence related to the COVID-19 pandemic. Canadian Medical Association Journal, 192(22). doi:10.1503/cmaj.200634

Feature image courtesy of Nicolas Moscarda on Unsplash​.